Our current data showed that knocking out PRKD3 led to the reduction of p‐ERK1, p‐c‐MYC (Ser62), total c‐MYC and the down‐regulated expression of c‐MYC target genes in breast cancer cells. The gene discussed is MYC; the disease is breast carcinoma.